NMN (Nicotinamide Mononucleotide)
An NAD+ precursor intensively studied in the context of cellular aging — human data are still early, despite huge market popularity.
Number of studies
2
Safety
Moderate
Time to effects
Human data are limited — in the available study, improved muscle insulin sensitivity was observed after 10 weeks of supplementation; effects on lifespan cannot be assessed over a short period.
Monthly cost
ok. 250–500 zł/miesiąc
Price in Poland
150–350 zł za 60 kapsułek 250 mg (2–4 tygodnie przy dawce 500–1000 mg/dobę)
Who it's for
Jeden z najdroższych suplementów w bazie — cena wynika z kosztownej syntezy czystego NMN.
Indicative prices for the Polish market — we don't point to specific retailers; the real price depends on the manufacturer, form and place of purchase.
Table of contents
TL;DR
An NAD+ precursor intensively studied in the context of cellular aging — human data are still early, despite huge market popularity.
- →In animals: improved insulin sensitivity, endurance and vascular function
- →In humans: small preliminary studies suggest improved physical performance — data are still limited
- →Preliminary data on improved muscle insulin sensitivity in women with prediabetes
| Chemical compound | Nicotinamide mononucleotide, an NAD+ precursor |
|---|---|
| Group | Longevity compound / NAD+ precursor (experimental area) |
| Form | Capsules or powder, taken orally |
| Dose used in studies | 250–1200 mg/day |
| Evidence level | Preliminary — few, small, short-term human studies |
| Interactions | None well documented (a poorly researched area) |
| Status | Experimental supplement, high price, no confirmed long-term effects in humans |
Understand
Overview
NMN (nicotinamide mononucleotide) is a precursor in the NAD+ (nicotinamide adenine dinucleotide) synthesis pathway — a coenzyme present in every cell of the body and essential for hundreds of metabolic reactions, including mitochondrial energy production and DNA repair. NAD+ levels naturally decline with age — in people 60 and older they can be as much as half those of young adults, which some researchers link to the general drop in metabolic fitness that accompanies aging.
NMN, alongside the related compound NR (nicotinamide riboside), became one of the most talked-about topics in the longevity world following publications by researcher Shin-ichiro Imai of Washington University and popularization by well-known aging researchers such as David Sinclair of Harvard. This drove a rapid surge in market popularity that has significantly outpaced the pace of solid, large-scale human clinical trials.
At this stage of the research, it's hard to point to a group that can confidently expect to 'feel' an NMN effect in the sense of a subjectively noticeable improvement — the available human clinical data are few, short-term, and focused on narrow, objectively measured parameters (for example, muscle insulin sensitivity in women with prediabetes in a 10-week study), rather than subjective well-being or energy. Realistically, NMN makes sense only for people deliberately experimenting at an early stage of the evidence, who accept the high cost and the lack of any guaranteed effect — it is not a first-choice supplement for people starting out in biohacking, nor for anyone expecting a fast, measurable difference. It's worth remembering that NMN's market popularity has clearly outpaced the emergence of large, long-term human clinical trials, and that evidence for lifespan extension comes mainly from animal models (mice, yeast, roundworms) — the current status of NMN in humans is a promising but still preliminary research hypothesis, not a confirmed anti-aging intervention.
History of use
As a chemical compound, NMN has long been known to biochemistry as a natural metabolic intermediate in the NAD+ pathway, but its career as a 'longevity' supplement began in the 21st century alongside research into the role of NAD+ in aging — work by Shin-ichiro Imai of Washington University played a key role, as did the popularization of NAD+ and sirtuins by David Sinclair of Harvard. It was this media attention, more than large human clinical trials, that most drove NMN's market popularity over the past decade.
Mechanism of action
NMN is absorbed and converted in the body into NAD+ via a two-step metabolic pathway (the so-called salvage pathway). NAD+ is an essential substrate for sirtuins (a group of enzymes that regulate DNA repair, inflammation and energy metabolism, and that have been linked to longevity in animal models), as well as for PARP enzymes involved in DNA damage repair. The research hypothesis — still actively being tested, not yet conclusively confirmed — holds that raising the NAD+ levels that decline with age, via precursor supplementation such as NMN, might slow certain aspects of cellular aging.
The enzyme NAMPT is the natural, rate-limiting step of endogenous NMN synthesis from nicotinamide in the body — its activity also declines with age, which is one of the reasons NAD+ levels fall during aging. After oral administration, NMN must be absorbed and delivered into cells — in mouse studies, a dedicated membrane transporter, Slc12a8, was identified as responsible for direct cellular uptake of NMN in the intestine, though its role in humans is still under investigation. Elevated NAD+ is a key substrate for sirtuins, particularly SIRT1 and SIRT3, enzymes that regulate inflammation, mitochondrial function and the response to metabolic stress — it is their activity in animal models that has been linked to the observed lifespan extension, though translating this mechanism to humans remains a hypothesis.
Endogenous NAD+ synthesis
The enzyme NAMPT converts nicotinamide into NMN in the body — the natural, rate-limiting step of the salvage pathway, whose activity declines with age.
Absorption and cellular uptake
NMN supplied via a supplement is absorbed and taken up by cells — in mice, a transporter called Slc12a8 has been described for this purpose, though its role in humans is still under study.
Conversion to NAD+
Inside the cell, NMN is converted into NAD+, raising the availability of this coenzyme for metabolic and repair reactions.
Activation of sirtuins and PARP
Elevated NAD+ fuels sirtuins (SIRT1, SIRT3) and PARP enzymes involved in DNA repair, inflammation and energy metabolism — linked to longevity in animal models.
Evidence: early-stage — based on 2 studies in this database.
Benefits
Common myths
MythNMN is a scientifically confirmed way to extend human lifespan.
FactEvidence for lifespan extension comes mainly from animal models (mice, yeast, roundworms) — there are not yet long-term human studies confirming such an effect.
MythSince NMN is so popular and expensive, it must be well researched.
FactMarket popularity has outpaced the emergence of large human clinical trials — this is still an area of active, early-stage research.
Forms & variants
NMN (Nicotinamide Mononucleotide) comes in several forms that differ in bioavailability and use case — the form you pick genuinely matters for how effective the supplementation is.
NMN (nicotinamide mononucleotide)
Structurally closer to the direct NAD+ precursor in the metabolic pathway than NR — studied more often in recent years in human clinical trials.
Best for: The default choice among NAD+ precursors given the current state of research
NR (nicotinamide riboside)
A related NAD+ precursor, previously approved for sale as a supplement ingredient in some countries (including the US) — has a separate, also preliminary, but somewhat longer history of clinical research than NMN.
Best for: An alternative to NMN, especially where NMN's regulatory availability is limited
Sublingual / powdered NMN
Promoted as bypassing partial breakdown in the digestive tract — there is no solid pharmacokinetic research directly comparing this form with oral capsules in humans.
Best for: No confirmed advantage — choice based on preference, not hard evidence
Practice
Frequently asked questions
Evidence for lifespan extension comes mainly from animal models (mice, yeast, roundworms). There are not yet long-term human studies confirming an effect on lifespan — this is an area of active research, not an established fact.
Strong preclinical (animal) results and media attention around NAD+'s role in aging have driven the supplement market faster than large human clinical trials can keep pace — it's worth keeping that distinction in mind when making decisions.
Both are NAD+ precursors with a similar, though not identical, mechanism of action. Neither yet has a large enough body of major human clinical trials to clearly favor one over the other — the choice largely comes down to availability and preference.
Dosage & timing
Typical dose
250–1200 mg/day in human clinical trials (still an experimental area)
Form
NMN in capsules or powder
Dosing is informational and reflects the ranges used in the cited studies — it does not replace consulting a doctor or pharmacist. This is an experimental-status compound — long-term safety and effectiveness in humans have not yet been confirmed by large studies.
Best times to take it
- Most often in the morning, on an empty stomach — based on common practice, not solid pharmacokinetic evidence
What to combine with
Good combinations
Resweratrol — A theoretically synergistic pairing (sirtuin activation plus NAD+ substrate), weakly confirmed clinically in humans
Safety
Side effects & contraindications
Possible side effects
Good tolerance at doses up to 1200 mg/day in short-term human studies to date
Contraindications
Pregnancy and lactation — no safety data
Cancer — theoretical concerns about NAD+'s effect on cell proliferation require further research
Interactions
No well-documented drug interactions — the area is still poorly researched
Is it worth taking?
Who it's for
- People deliberately experimenting with early-stage supplementation, who accept the high cost and uncertainty of outcomes
- Not a first-choice supplement for people new to biohacking
Not for
- Pregnancy and lactation — no safety data
- Cancer — theoretical concerns about NAD+'s effect on cell proliferation require further research
Evidence
Worth knowing
NMN is a precursor of NAD+ — a coenzyme whose level naturally declines with age, by as much as half in people 60 and older.
NR (nicotinamide riboside) is a related, alternative NAD+ precursor with a separate, also early, research history.
In short-term human studies to date, tolerance at doses up to 1200 mg/day has been good.
Studies
In a randomized trial in women with prediabetes, 10 weeks of NMN supplementation improved muscle insulin sensitivity, though it had no significant effect on body weight or other metabolic markers.
Yoshino M, et al., Science, 2021
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Early-stage evidenceYoshino M, et al. · Science · 2021
A randomized trial (n=25) in women with prediabetes showing improved muscle insulin sensitivity after 10 weeks of supplementation — no significant effect on body weight or other markers.
View studySafety evaluation of β-nicotinamide mononucleotide in healthy adults
Early-stage evidenceKim M, et al. · Frontiers in Aging Neuroscience · 2022
A safety study showing good tolerance of doses up to 500 mg/day over 12 weeks in healthy adults.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.
26 publications on this site
Medical review
dr Piotr ZielińskiEndocrinologist
Piotr reviews content on hormones, metabolic health and supplement pharmacology.
47 publications on this site
Related entries
3.9Resveratrol
The red-grape polyphenol famed as a 'sirtuin activator' — but its bioavailability in humans is very low, which limits the practical relevance of many striking test-tube results.
4.9Strength Training
One of the single strongest predictors of healthy aging — it shapes muscle mass, bone density, and insulin sensitivity.
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.